|
Re: Outfits like ActiveWallStreet....... rec'd
|
2
|
Resverlogix Corp.
|
Dec 07, 2016 08:02PM
|
|
Re: Pitchforks
|
5
|
Resverlogix Corp.
|
Dec 19, 2020 08:34AM
|
|
Re: Possibile deals for both RVX and Zenith
|
2
|
Resverlogix Corp.
|
Oct 17, 2017 09:52AM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
4
|
Resverlogix Corp.
|
Nov 14, 2022 06:49PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 14, 2022 07:48PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
1
|
Resverlogix Corp.
|
May 14, 2022 08:28PM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 09, 2021 05:47PM
|
|
Re: Rant time...
|
4
|
Resverlogix Corp.
|
Feb 05, 2021 10:37AM
|
|
Re: Rant time...
|
|
Resverlogix Corp.
|
Feb 05, 2021 11:32AM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
8
|
Resverlogix Corp.
|
Dec 05, 2019 07:03PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 07:42PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
1
|
Resverlogix Corp.
|
Dec 05, 2019 07:49PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 07:57PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
2
|
Resverlogix Corp.
|
Dec 05, 2019 08:33PM
|
|
Re: Research Reports Initiated: just their nr and link...
|
1
|
Resverlogix Corp.
|
Dec 06, 2016 12:35PM
|
|
Re: Research Reports Initiated: just their nr and link...
|
1
|
Resverlogix Corp.
|
Dec 06, 2016 08:44PM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
5
|
Resverlogix Corp.
|
Mar 14, 2021 11:02AM
|
|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
7
|
Resverlogix Corp.
|
Mar 14, 2021 07:08PM
|
|
Re: Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
8
|
Resverlogix Corp.
|
Jan 18, 2022 08:33AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
11
|
Resverlogix Corp.
|
Jun 13, 2023 08:02AM
|
